ENABLE LIFE SCIENCES LLC
Farmington, CT · Biotech · Private
Cancer-specific monoclonal antibodies combined with adoptive Natural Killer (NK) cell immunotherapy for personalized cancer treatment
- Grants
- $499K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Novel Serum Alternative for Ex-vivo Expansion of Natural Killer Cells for Immunotherapy | $224,000 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Antibody Therapy that Targets Neoantigens in Acute Myeloid Leukemia via the Antibody Dependent Cell-mediated Cytotoxicity Mechanism of Natural Killer Cells | $274,975 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2177 | PARTILLION BIOSCIENCE CORPORATION | — | — |
| 2178 | AVADIM HEALTH, INC. | — | $81M |
| 2179 | ID4PHARMA, LLC | — | — |
| 2180 | ENABLE LIFE SCIENCES LLC | — | — |
| 2181 | General Counsel AI, Inc. | — | $63M |
| 2182 | GIWOTECH INC. | — | — |
| 2183 | City Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Process For Producing Personalized Cancer Immunotherapyapplication
- Process For Producing Personalized Cancer Immunotherapyapplication
- Cell Culture Medium For Natural Killer (nk) Cellsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.